Alterity Therapeutics-ADRATHE
13F holders, Q2 2025 (June 30)11holders −1
2new positions
3sold out
1famous investor
$4.09avg. 13F price*
At the end of Q2 2025, 11 institutions reported holding Alterity Therapeutics-ADR (ATHE) in their 13F filings, down 1 from Q1 2025. 2 opened new positions and 3 sold out. The largest holders were Point72 Asset Management ($537K), Morgan Stanley ($238K) and Greenleaf Trust ($70K). One famous investor held it Steve Cohen (0.0% of Point72 Asset Management's portfolio).
- Company
- Alterity Therapeutics-ADR
- CUSIP
- 02155X205
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $72K |
| Exits | 3 | $174K |
All 13F filers, Q1 2025 → Q2 2025: 32,228 shares bought and 52,102 shares sold, net −19,874 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 11 holders
| Point72 Asset Management | 0.00% | No change | 131,431 | $537K |
| Morgan Stanley | 0.00% | Add +33.4% | 58,301 | $238K |
| Greenleaf Trust | 0.00% | New | 17,000 | $70K |
| BNP Paribas Financial Markets | 0.00% | Reduce -16.0% | 8,190 | $33K |
| Twin Lakes Capital Management, LLC | 0.01% | No change | 5,925 | $24K |
| EverSource Wealth Advisors, LLC | 0.00% | New | 628 | $3K |
| Osaic Holdings, Inc. | 0.00% | No change | 181 | $740 |
| Rhumbline Advisers | 0.00% | No change | 130 | $533 |
| Blue Trust, Inc. | 0.00% | No change | 40 | $164 |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 6 | $25 |
| Danske Bank A/S | 0.00% | No change | 1 | $4 |
"% of holder's portfolio" is ATHE's weight in each manager's 13F, not the share of Alterity Therapeutics-ADR the manager owns.